Academic Title:
Research Associate
Primary Appointment:
Medicine
Additional Title:
Research Associate
Location:
725 W Lombard St, Baltimore, MD 21201, USA.
Phone (Primary):
410-706-1438
Education and Training
1995-1998 B.S., Zoology, Bharathidasan University, Tiruchirappalli, India
1998-2000 M.S., Zoology, Bharathidasan University, Tiruchirappalli, India
2000-2001 M.Phil., Zoology, University of Madras, Chennai, India
2001-2006 Ph.D., Zoo-Biochemistry, University of Madras, Chennai, India
2006-2007 Honorary Visiting Fellow, University of New South Wales, Sydney, Australia
2008-2009 Research Associate, Ajou University, Suwon, South Korea
2009-2014 Visiting Research Fellow, National Institutes of Health, Bethesda, MD, USA
2014-2015 Sr. Postdoctoral Fellow, Medical College of Wisconsin, Milwaukee, WI, USA
2015- 2016 Postdoctoral Research Scholar, University of Iowa, Iowa City, IA, USA
2016- 2021 Postdoctoral Fellow, IHV, University of Maryland School of Medicine, Baltimore, MD, USA
Biosketch
Research interests on cellular and molecular mechanism of various virus pathogenesis (Hepatitis B, Hepatitis C, HIV, COVID-19, EBOV, Respiratory Syncytial and Influenza Viruses), immune regulation of infectious diseases in human, mouse and cell line models. Mainly focused on the molecular mechanism of innate (IFNs & Cytokines) and adaptive immunity (T/B lymphocytes) and involvement of signaling pathways like TLR/NLR, RIG-I/MDA5, Type I/II IFNs, B/T Cell Receptors and MAPK.
Research/Clinical Keywords
I have been working on the pathogenesis of chronic hepatitis viral infections and my research elucidates the molecular and cellular pathways critical for persistence of Hepatitis B, Hepatitis C and HIV virus infections. Clinical trials for Chronic hepatitis infection, HIV, Liver Fibrosis, Viral Immunology, Restoration of Innate and Adaptive Immune cells Responses, immunomodulatory strategies.
Highlighted Publications
1. Ayithan, N, Tang, L., Tan, S., Chen, D., Wallin, J., Fletcher, S., Kottilil, S. and Poonia, B. Follicular helper T (TFH) cell targeting by TLR8 signaling for improving HBsAg-specific B cell response in chronic hepatitis B patients. Front. Immunol. 12: 735913 (2021).
2. Khanam, A., Ayithan, N., Tang, L., Poonia, B. and Kottilil, S. IL-21 deficient T follicular helper cells support B cell responses through IL-27 in patients with chronic hepatitis B. Front. Immunol. 11: 599648 (2021).
3. Reyes, M., Lutz, JD., Lau, AH., Gaggar, A., Grant, EP., Joshi, A., Mackman, RL., Ling, J., Tan, SK., Ayithan, N., Daffis, S., Woo, J., Wu, P., Lam, T., Fletcher, SP., Kottilil, S., Poonia, B., Gane, EJ., Mathias, A. and German, P. Safety, pharmacokinetics and pharmacodynamics of selgantolimod, an oral toll-like receptor 8 agonist: a Phase Ia study in healthy subjects. Antivir. Ther. 25 (3): 171-180 (2020).
4. Kim, JH., Ghosh, A., Ayithan, N., Romani, S., Khanam, A., Park, JJ., Rijnbrand, R., Tang, L., Sofia, MJ., Kottilil, S., Moore, CB. and Poonia, B. Publisher Correction: Circulating serum HBsAg level is a biomarker for HBV-specific T and B cell responses in chronic hepatitis B patients. Sci. Rep. 10 (1): 5947 (2020).
5. Poonia, B., Ayithan, N., Nandi, M., Masur, H. and Kottilil, S. HBV induces inhibitory FcRL receptor on B cells and dysregulates B cell-T follicular helper cell axis. Sci. Rep. 8 (1): 15296 (2018).
6. Ayithan N, Bradfute S, Anthony SM, Stuthman KS, Dye JM, Bavari S, Bray M, Ozato K. Ebola virus-like particles stimulate type I Interferons and pro-inflammatory cytokine expression through the toll-like receptor and interferon signaling pathways. J. Interferon Cytokine Res., 34(2): 79-89 (2014).
7. Ayithan N, Bradfute S, Anthony SM, Stuthman KS, Bavari S, Bray M, Ozato K. Virus like particles activate type I interferons pathway to facilitate post-exposure protection against Ebola virus infection. PLoS One. 10(2): e0118345 (2015).
8. Bradfute SB, Anthony SM, Stuthman KS, Ayithan N, Tailor P, Bray M, Ozato K, Bavari S . Mechanisms of immune protection in post-exposure vaccination against Ebola virus infection. PLoS One. 10(3): e0118434 (2015).
9. Imai Y, Ayithan N, Wu X, Yuan Y, Wang L, Hwang ST . Cutting edge: PD-1 regulates imiquimod-induced psoriasiform dermatitis through inhibition of innate IL-17A expression by γδ low T cells. J. Immunol. 195 (2): 421-425 (2015).
10. Li N, Xu W, Yuan Y, Ayithan N, Imai Y, Wu X, Miller H, Olson M, Feng Y, Huang Y, Jo Turk M, Hwang ST, Malarkannan S, Wang L. Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis. Sci. Rep. 7 (1): 1485 (2017).
11. Brouillette, RB, Phillips, EK, Ayithan, N. and Maury, W. Differences in glycoprotein complex receptor binding site accessibility prompt poor cross-reactivity of neutralizing antibodies between closely related Arenaviruses. J. Virol. 91 (7): e01454-16 (2017).
12. Devaraj, H. and Natarajan, A. Molecular mechanisms regulating molting in a crustacean. FEBS Journal, 273 (4): 839-846 (2006).
Additional Publication Citations
1. Grant, E., Joshi, A., Ayithan, N., Daffis, S., Woo, J., Lam, T., Mackman, RL., Fletcher, S., Gaggar, A., Lau, AH., Kottilil, S. and Poonia, B. Pharmacodynamic response to oral administration of the selective toll-like receptor 8 agonist GS-9688 in healthy volunteers. Hepatology 68: 270A (2018).
2. Sinn, PL., Coffin, JE., Ayithan, N., Holt, KH. and Maury, W. Lentiviral vectors pseudotyped with filoviral glycoproteins. Methods Mol. Biol. 1628: 65-78 (2017).
3. Li, N., Wu, X., Yuan, Y., Ayithan, N., Imai, Y., Wu, X., Miller, H., Olson, M., Hwang, ST., Malarkannan, S. and Wang, L. Immune checkpoint protein VISTA is a critical regulator of the IL-23/IL-17 inflammatory axis. Cancer Res. 77 (13): 468 (2017).
4. Imai, Y., Wu, X., Ayithan, N., Wang, L. and Hwang, S. PD-1 regulates imiquimod-induced psoriasiform dermatitis through inhibition of innate IL-17A expression by gamma delta low T Cells. J. Invest. Dermatol. 135: S93 (2015).
5. Ozato, K., Sarai, N., Patel, M., Ayithan, N. and Tamura, T. Chromatin dynamics in interferon signaling: Analysis of the histone H3.3 deposition. Cytokine 52 (1): 15-16 (2010).
Research Interests
The research projects aimed to understand the role of virus specific immunological responses that are defective in these persistence infections as well as understanding mechanisms that cause these defects. In collaboration with Gilead Sciences Foster City, CA, I completed Phase 1a, Phase1b and Phase 2 clinical trials in Chronic Hepatitis B patients using Oral Selective TLR8 agonist, Selgantolimod. Currently, I am developing the combinatorial immunomodulatory strategies for functional cure in Chronic hepatitis patients.
Clinical Specialty Details
I investigated phase 1a, phase1b and phase 2 clinical trials (translational research) using human oral selective-TLR8 agonist (Selgantolimod) drug treatment in healthy volunteers as well as CHB patients to study the coordinated responses of different immune cells and identify the key immune correlates which target the virus and the host for immunological cure. My findings achieved the development of immunological methods that are required for examining the defective immune cell activation, cytokine responses and improved HBsAg-specific antibody production which are key players for the reduction of hepatitis viral replications, viral clearance and enhance the host immune cell functions that lead to physiological cure. My study will also support the clinical trials to find out more efficient vaccine cohorts which will help to recover the defective immune system and control the hepatitis viral infections.
Awards and Affiliations
2006-2007 - Honorary Visiting Fellowship, St. George Clinical School, University of New South Wales, Sydney, Australia.
2009-2014 - Visiting Research Fellowship - NICHD, National Institute of Health, Bethesda, Maryland.
2015-2016 - Postdoctoral Research Scholarship - University of Iowa Carver College of Medicine, Iowa City, IA.
Grants and Contracts
2001-2003 - Ph.D. Grant Fellowship Award from the Department of Science and Technology (DST), Government of India, India.
2003-2006 - Senior Research Fellowship Award from the Department of Science and Technology (DST), Government of India, India.
2008-2009 - Brain Korean (BK21) Research Fellowship - Ajou University, South Korea.
Professional Activity
2010 - General Member and Peer Reviewer, International Society for Antiviral research
2014 - General Member and Peer Reviewer, International Journal of Infectious Diseases
2020 - Peer Reviewer, International Journal of Infectious Diseases and Therapy
2020 - Editorial Board Member, International Journal of Infectious Diseases and Therapy